4/29
01:03 pm
biib
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $270.00 price target on the stock.
Low
Report
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $270.00 price target on the stock.
4/29
12:48 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/29
12:48 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/25
02:01 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/25
02:01 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/25
08:30 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/25
08:30 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/25
05:31 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/25
05:31 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/24
08:39 am
biib
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Low
Report
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
4/24
08:32 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/24
08:32 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/19
10:51 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/19
10:51 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/17
12:54 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/17
12:54 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/11
08:48 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/4
09:19 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/4
09:19 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
4/1
05:23 pm
biib
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at William Blair.
4/1
05:23 pm
biib
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at William Blair.
3/5
10:35 am
biib
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $364.00 price target on the stock.
Low
Report
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $364.00 price target on the stock.
3/5
10:35 am
biib
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $364.00 price target on the stock.
Low
Report
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $364.00 price target on the stock.
3/5
09:48 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
3/5
09:48 am
biib
Rating for BIIB
Low
Report
Rating for BIIB